Related Experiment Video
Updated: Jul 13, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Patient preferences for asthma therapy: a discrete choice experiment
Andrew Lloyd1, Emma McIntosh, Klaus F Rabe
1Deputy Director Europe, United BioSource Corporation, 20 Bloomsbury Square, London, WC1A 2NS, UK. andrew.lloyd@unitedbiosource.com
Summary
Patients value symptom-free days and avoiding asthma attacks, indicating a significant willingness to pay for better asthma management. This highlights the importance of effective asthma treatments for improving quality of life.
Area of Science:
- Pulmonary Medicine
- Health Economics
- Patient-Reported Outcomes
Background:
- Asthma management requires understanding patient priorities to optimize treatment strategies.
- Patient preferences significantly influence adherence and satisfaction with asthma therapies.
Purpose of the Study:
- To determine patient preferences for various asthma treatment attributes across three European countries.
- To quantify the value patients place on symptom reduction and avoidance of severe exacerbations.
Main Methods:
- A survey was conducted with asthma patients in the UK, Netherlands, and Spain (total n=379).
- Patients' willingness to pay was assessed for avoiding symptom days, emergency visits, and achieving symptom-free states.
Main Results:
- Participants were willing to pay €35/month to avoid a symptom day.
- A higher value (€109/month) was placed on avoiding asthma attacks requiring emergency care.
- Patients valued total symptom avoidance at €94/month compared to their current condition.
Conclusions:
- European patients highly value symptom control and the avoidance of asthma attacks needing medical intervention.
- These findings underscore the importance of effective asthma treatments in improving patient quality of life and reducing healthcare burden.
More Related Videos
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:25Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.